Zhou Kaisheng, Wu Shaobo, Wu Zuolong, Ran Rui, Song Wei, Dong Hao, Zhang Haihong
Department of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, China.
Orthopaedics Key Laboratory of Gansu Province, Lanzhou, China.
Sci Rep. 2024 Dec 3;14(1):30138. doi: 10.1038/s41598-024-81681-8.
Intervertebral disc degeneration (IDD) is a prevalent spinal disorder and the principal cause of lower back pain (LBP). Diverse forms of programmed cell death (PCD) have been identified as the key phenotypes of the disease and have the potential to serve as new indicators for the diagnosis and prognosis of IDD. However, the mechanism underlying necroptosis in IDD remains unclear. This study aimed to identify novel biomarkers that promote nucleus pulposus cell necroptosis in IDD using bioinformatic analysis and experimental validation. We analyzed multiple datasets of IDD from the Gene Expression Omnibus (GEO) database to identify necroptosis-related IDD differential genes (NRDEGs). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed, followed by logistic least absolute shrinkage and selection operator (LASSO) and support vector machine-recursive (SVM) algorithms to identify key genes. Gene set enrichment analysis (GSEA) and logistic regression analysis were used to ascertain the potential functions of these genes and to identify key genes, respectively. We then constructed mRNA-miRNA, mRNA-TF, mRNA-drug, and functional similarity gene interaction networks for the seven key genes identified. We used IDD clinical samples and necroptotic cell model to validate our findings. Immunohistochemical staining, RT-qPCR, and western blotting results indicated that IRF1 may be a hub necroptosis-related gene. To further elucidate the function of IRF1, we constructed IRF1 knockdown and overexpression models, which revealed that IRF1 promotes necroptosis in rat nucleus pulposus cells, increases mitochondrial ROS levels, and decreases ATP levels. These findings provide new insights into the development of necroptosis in IDD and, for the first time, validate the role of IRF1 as a novel biomarker for the diagnosis and treatment of IDD.
椎间盘退变(IDD)是一种常见的脊柱疾病,也是下腰痛(LBP)的主要原因。多种形式的程序性细胞死亡(PCD)已被确定为该疾病的关键表型,并有潜力作为IDD诊断和预后的新指标。然而,IDD中坏死性凋亡的潜在机制仍不清楚。本研究旨在通过生物信息学分析和实验验证,确定促进IDD中髓核细胞坏死性凋亡的新型生物标志物。我们分析了来自基因表达综合数据库(GEO)的多个IDD数据集,以识别与坏死性凋亡相关的IDD差异基因(NRDEGs)。进行了基因本体论(GO)和京都基因与基因组百科全书(KEGG)分析,随后采用逻辑最小绝对收缩和选择算子(LASSO)及支持向量机递归(SVM)算法来识别关键基因。基因集富集分析(GSEA)和逻辑回归分析分别用于确定这些基因的潜在功能并识别关键基因。然后,我们为鉴定出的7个关键基因构建了mRNA- miRNA、mRNA-TF、mRNA-药物和功能相似性基因相互作用网络。我们使用IDD临床样本和坏死性凋亡细胞模型来验证我们的发现。免疫组织化学染色、RT-qPCR和蛋白质印迹结果表明IRF1可能是一个与坏死性凋亡相关的关键基因。为了进一步阐明IRF1的功能,我们构建了IRF1敲低和过表达模型,结果显示IRF1促进大鼠髓核细胞的坏死性凋亡,增加线粒体ROS水平,并降低ATP水平。这些发现为IDD中坏死性凋亡的发生发展提供了新的见解,并首次验证了IRF1作为IDD诊断和治疗的新型生物标志物的作用。